HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1384008Generated: October 30, 2026
Sodium hydride → 4-(Ethenyl)-2-[(4-chlorophenoxy)methyl]-1-[3-[1-(t-butoxycarbonyl)piperidin-4-yl]propyl]benzimidazole
https://huagongshe.com/reaction/1384008
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | tert-Butyl 4-(3-bromopropyl)piperidine-1-carboxylate | HCID 18409081 | — |
| Reactant | HCID 178435861 | HCID 178435861 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 4-(Ethenyl)-2-[(4-chlorophenoxy)methyl]-1-[3-[1-(t-butoxycarbonyl)piperidin-4-yl]propyl]benzimidazole | HCID 21188544 | — |
Reaction Steps
In a 100 ml round bottom flask, under a nitrogen atmosphere, were added 4-(ethenyl)-2-[(4-chlorophenoxy)methyl]benzimidazole (670 mg, 2.24 mmol) and anhydrous N,N-dimethylformamide (34 ml). To this solution was added sodium hydride (60% in mineral oil, 98.67 mg, 2.46 mmol). The resulting mixture was stirred at room temperature for 45 minutes, and then 3-[1-(t-butoxycarbonyl)piperidin-4-yl]propyl bromide (755 mg, 2.47 mmol) was added. The resulting mixture was heated to 100° C. and stirred at this temperature for about four hours. The progress of the reaction was monitored by thin layer chromatography. The reaction mixture was partitioned between ethyl acetate and brine. The aqueous fraction was extracted twice with brine. The organic fractions were combined and dried over sodium sulfate. The solvents were removed in vacuo. The desired title product was further purified by radial chromatography.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06255494B1 |
|---|
| Source dataset | uspto-grants-2001_07 |
|---|
| ORD ID | ord-49685daffb6a45f79d781ac53ad5a5d0 |
|---|
| Source note | uspto-grants-2001_07 |
|---|